Literature DB >> 8294684

Neointimal coverage of stents in human coronary arteries observed by angioscopy.

Y Ueda1, S Nanto, K Komamura, K Kodama.   

Abstract

OBJECTIVES: The aim of this study was to reveal the time course of the neointimal coverage of stents placed in the human coronary arteries.
BACKGROUND: In deciding the protocol of anticoagulant and antiplatelet therapy for patients who undergo stent implantation, the condition of the neointimal coverage of stents should be taken into consideration. However, the time course of the neointimal coverage of stents has not been elucidated in human coronary arteries.
METHODS: Serial angioscopic observations were performed immediately after stenting, at 8 to 45 days (short-term follow-up) and at 65 to 142 days (long-term follow-up) in patients who underwent implantation of the Wiktor coronary stent in the restenotic lesion or in the lesion of acute or threatened closure after balloon angioplasty.
RESULTS: Angioscopic observations were successfully performed in 14 cases immediately after stenting, in 11 cases at short-term follow-up and in 13 cases at long-term follow-up. Immediately after stenting and even at 8 to 18 days after stenting, the stent was not covered by the neointimal layer in any case. However, at 65 to 142 days after stenting, the stent was covered by the neointimal layer in all cases. Angioscopically, three types of neointimal layer were recognized: a white layer with a cottonlike surface in three cases, a white layer with a smooth surface in eight cases and a transparent layer with a smooth surface in two cases.
CONCLUSIONS: Although some experimental results in animals have shown completion of neointimal coverage of stents in a few weeks, in this serial angioscopic follow-up study, the completion of neointimal coverage of stents in human coronary arteries required approximately 3 months.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294684     DOI: 10.1016/0735-1097(94)90417-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

1.  Diagnostic value of myocardial SPECT to detect in-stent restenosis after drug-eluting stent implantation.

Authors:  Hyo Eun Park; Bon-Kwon Koo; Kyung-Woo Park; Jin Chul Paeng; Hae-Young Lee; Hyun-Jae Kang; Hyo-Soo Kim
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-07       Impact factor: 2.357

2.  Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Per Olav Vandvik; A Michael Lincoff; Joel M Gore; David D Gutterman; Frank A Sonnenberg; Pablo Alonso-Coello; Elie A Akl; Maarten G Lansberg; Gordon H Guyatt; Frederick A Spencer
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Improving the visual field in coronary artery by with non-obstructive angioscopy: dual infusion method.

Authors:  Sei Komatsu; Tomoki Ohara; Satoru Takahashi; Mitsuhiko Takewa; Chikao Yutani; Kazuhisa Kodama
Journal:  Int J Cardiovasc Imaging       Date:  2017-02-07       Impact factor: 2.357

4.  A higher colour grade yellow plaque was detected at one year after implantation of an everolimus-eluting stent than after a zotarolimus-eluting stent.

Authors:  Koshi Matsuo; Yasunori Ueda; Mayu Nishio; Akio Hirata; Mitsutoshi Asai; Takayoshi Nemoto; Ayaka Murakami; Kazunori Kashiwase; Kazuhisa Kodama
Journal:  Heart Asia       Date:  2013-09-07

5.  Chronic kidney disease and coronary artery vulnerable plaques.

Authors:  Mitsuru Wada; Yasunori Ueda; Tomoaki Higo; Koshi Matsuo; Mayu Nishio; Akio Hirata; Mitsutoshi Asai; Takayoshi Nemoto; Toshikazu Kashiyama; Ayaka Murakami; Kazunori Kashiwase; Kazuhisa Kodama
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

6.  Dual antiplatelet therapy duration after the placement of a drug-eluting stent: what are the data?

Authors:  Jad Raffoul; Andrew J P Klein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

7.  Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions.

Authors:  Roberta Rossini; Giuseppe Musumeci; Eliano Pio Navarese; Giuseppe Tarantini
Journal:  Am J Cardiovasc Dis       Date:  2013-02-17

8.  Optimization of Drug Delivery by Drug-Eluting Stents.

Authors:  Franz Bozsak; David Gonzalez-Rodriguez; Zachary Sternberger; Paul Belitz; Thomas Bewley; Jean-Marc Chomaz; Abdul I Barakat
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

Review 9.  Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice.

Authors:  Min Soo Cho; Duk-Woo Park
Journal:  Korean J Intern Med       Date:  2017-08-22       Impact factor: 2.884

10.  Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation.

Authors:  Takayuki Ishihara; Yohei Sotomi; Takuya Tsujimura; Osamu Iida; Tomoaki Kobayashi; Yuma Hamanaka; Takashi Omatsu; Yasushi Sakata; Yoshiharu Higuchi; Toshiaki Mano
Journal:  Cardiovasc Diabetol       Date:  2020-12-02       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.